Monopar Therapeutics, Inc. (MNPR)
NASDAQ: MNPR · IEX Real-Time Price · USD
1.83
-0.03 (-1.35%)
At close: Aug 10, 2022 3:36 PM
1.81
-0.01 (-0.82%)
After-hours:
Aug 10, 2022 4:00 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|
Selling, General & Admin
|
2.63 | 2.44 | 2.36 | 1.56 | 1.17 | 0.91 |
Research & Development
|
6.49 | 4.07 | 1.97 | 1.77 | 0.94 | 0.28 |
Other Operating Expenses
|
0 | 0 | 0 | 0 | 14.5 | 0 |
Operating Expenses
|
9.13 | 6.51 | 4.32 | 3.33 | 16.6 | 1.19 |
Operating Income
|
-9.13 | -6.51 | -4.32 | -3.33 | -16.6 | -1.19 |
Other Expense / Income
|
-0.02 | -0.2 | -0.1 | -0.1 | -0.05 | -0.01 |
Pretax Income
|
-9.1 | -6.3 | -4.22 | -3.23 | -16.55 | -1.19 |
Net Income
|
-9.1 | -6.3 | -4.22 | -3.23 | -16.55 | -1.19 |
Net Income Common
|
-9.1 | -6.3 | -4.22 | -3.23 | -16.55 | -1.19 |
Shares Outstanding (Basic)
|
12 | 11 | 9 | 9 | 9 | 9 |
Shares Outstanding (Diluted)
|
12 | 11 | 9 | 9 | 9 | - |
Shares Change
|
13.82% | 17.56% | 0.32% | 5.80% | - | - |
EPS (Basic)
|
-0.73 | -0.58 | -0.45 | -0.35 | -1.89 | - |
EPS (Diluted)
|
-0.73 | -0.58 | -0.45 | -0.35 | -1.89 | - |
Free Cash Flow Per Share
|
-0.59 | -0.42 | -0.32 | -0.29 | -0.30 | -0.13 |
EBITDA
|
-9.1 | -6.3 | -4.22 | -3.23 | -16.55 | -1.19 |
EBIT
|
-9.1 | -6.3 | -4.22 | -3.23 | -16.55 | -1.19 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).